Dev

Dev

EMA issues draft guidelines for ALS treatment

The European Medicines Agency has released a draft guideline on the clinical investigation of medicines for the treatment of amyotrophic lateral sclerosis (ALS) for a six-month public consultation. The document focuses on the design of studies for medicines that have…

New JPND Scientific Advisory Board Members

Representatives of industry and patient organisations have joined the JPND Scientific Advisory Board Since 2010, the JPND Scientific Advisory Board (SAB) has been delivering independent, strategic advice to the JPND Management Board for: the establishment of its Strategic Research Agenda…

Brian Fiske

Scientific Representative of The Michael J. Fox Foundation for Parkinson’s Research. Brian K. Fiske, PhD, is Vice President of Research Programs at The Michael J. Fox Foundation for Parkinson’s Research. In this role, he manages a team of research professionals…

New funding for pathfinder projects between Centres of Excellence

Five new innovative pathfinder projects are being funded under the JPND-aligned CoEN initiative The Centres of Excellence in neurodegenerative disease (CoEN) initiative, launched in 2010, funds collaborative research in the field of neurodegenerative disease, spanning disorders such as Alzheimer’s, Parkinson’s…

TRACK-HD latest results published

The most recent findings have been published from the TRACK-HD study, designed to create an unprecedentedly detailed map of changes in prodromal and early Huntington’s disease. The latest findings from the TRACK-HD study are published in The Lancet Neurology and…

Post
Filter